Quantum Surgical’s Bertin Nahum continues the discussion on the evolution of surgical robotics at DeviceTalks West
The evolution of the surgical robotics field has been fascinating to watch and, of course, to talk about with leaders in the space.
To that end, I can’t wait to connect with Bertin Nahum of Quantum Surgical who will join us on Oct. 19 on our keynote panel, How Surgical Robotics Companies Are Following the Shifting Centers of Care.
At first glance, Quantum’s Epione robot looks like a small step in this evolutionary scale. But Nahum – who founded one of the first successful surgical robotics companies, Medtech S.A., (sold to Zimmer Biomet in 2016) – rightly notes that Quantum’s approach brings the image guided functionality of hard tissue systems into soft tissue surgery, making minimally invasive cancer ablation possible.
Just listen to our current interview on the DeviceTalks Weekly Podcast. A few notable quotes worth sharing.
- “What robots are good at is to help physicians perform high value procedures for patients that are otherwise very difficult to perform.”
- “When you are capable of performing a procedure in a minimally invasive way, patient benefits are indisputable as compared to an open procedure.”
- “We estimate that less than 20% of eligible patients benefit from this minimal invasive treatment.”
I highly recommend you listen to this interview. But you should join us at DeviceTalks West.
*****
Connect with Bertin Nahum and the rest of the panelists in person at DeviceTalks West, October 18-19 in Santa Clara, Ca. and visit the DeviceTalks Weekly podcast to tune into Nahum’s episode and other episodes featuring interviews with medtech’s top executives.
Listen now: CEO Nahum explains how Quantum Surgical is positioned for robotic surgery’s next evolutionary stage
